Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Return on Assets: 2022-2025

Historic Return on Assets for Molecular Partners Ag (MOLN) over the last 4 years, with Sep 2025 value amounting to -594.68%.

  • Molecular Partners Ag's Return on Assets fell 12264.00% to -594.68% in Q3 2025 from the same period last year, while for Sep 2025 it was -594.68%, marking a year-over-year decrease of 12264.00%. This contributed to the annual value of -306.35% for FY2024, which is 2641.00% down from last year.
  • As of Q3 2025, Molecular Partners Ag's Return on Assets stood at -594.68%, which was down 5.76% from -562.29% recorded in Q2 2025.
  • Molecular Partners Ag's 5-year Return on Assets high stood at 455.30% for Q1 2023, and its period low was -594.68% during Q3 2025.
  • For the 3-year period, Molecular Partners Ag's Return on Assets averaged around -223.99%, with its median value being -431.26% (2024).
  • Per our database at Business Quant, Molecular Partners Ag's Return on Assets skyrocketed by 59,497bps in 2023 and then slumped by 88,685bps in 2024.
  • Over the past 4 years, Molecular Partners Ag's Return on Assets (Quarterly) stood at 434.32% in 2022, then tumbled by 80,682bps to -372.49% in 2023, then tumbled by 6,405bps to -436.54% in 2024, then crashed by 12,264bps to -594.68% in 2025.
  • Its last three reported values are -594.68% in Q3 2025, -562.29% for Q2 2025, and -463.78% during Q1 2025.